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Abstract
OBJECTIVE—To estimate determinants of and outcomes associated with activity restriction
among women with a short cervix.
METHODS—This was a secondary analysis of a randomized trial of 17-α hydroxyprogesterone
caproate for prevention of preterm birth among nulliparous women with singleton gestations and
cervices less than 30 mm by midtrimester ultrasonography. Women were asked weekly whether
they had been placed on pelvic, work, or nonwork rest. “Any activity restriction” was defined as
being placed on any type of rest. Factors associated with any activity restriction were determined
and the association between preterm birth and activity restriction was estimated with multivariable
logistic regression.
RESULTS—Of the 657 women in the trial, 646 (98%) responded to questions regarding activity
restriction. Two hundred fifty-two (39.0%) were placed on any activity restriction at a median of
23.9 weeks (interquartile range 22.6–27.9 weeks).Women on activity restriction were older, more
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likely to have private insurance, less likely to be Hispanic, had a shorter cervical length, and were
more likely to have funneling and intra-amniotic debris. Preterm birth at less than 37 weeks of
gestation was more common among women placed on activity restriction (37% compared with
17%, P<.001). After controlling for potential confounding factors, preterm birth remained more
common among those placed on activity restriction (adjusted odds ratio 2.37, 95% confidence
interval 1.60–3.53). Results were similar for preterm birth at less than 34 weeks of gestation.
CONCLUSION—Activity restriction did not reduce the rate of preterm birth in asymptomatic
nulliparous women with a short cervix.
Preterm birth remains a leading cause of perinatal morbidity and mortality.1 In an effort to
reduce its frequency, investigators have studied a wide variety of prophylactic and
therapeutic strategies such as antibiotics, intravenous fluids, and both short-term and long-
term tocolysis. None of these strategies, however, has been proven to reduce the frequency
of preterm birth.2
Similarly, activity restriction has been widely studied for preterm birth prophylaxis and
treatment.3–5 Activity restriction takes many forms, including pelvic rest, work stoppage,
and bed rest. None of these variations is known to be efficacious, and each may be
associated with adverse social, economic, and health consequences.6,7
Two randomized trials have demonstrated that vaginal progesterone, when administered to
women found to have a short cervix on transvaginal ultrasonography, reduces the frequency
of preterm birth.8,9 Accordingly, some have advocated for midtrimester cervical length
screening for all pregnant women.10 Others, however, have urged caution, noting the
possibility of unanticipated, potentially unhelpful, and costly strategies that may be enacted
in response to the finding of a short cervix.11 This study was designed to estimate the extent
to which women with a short cervix have activity restriction recommended and to estimate
the association between this intervention and preterm birth.
MATERIALS AND METHODS
The Short Cervix and Nulliparity trial was a randomized placebo-controlled trial in which
asymptomatic nulliparous women with singleton gestations and a cervices less than 30 mm
(ie, less than the tenth percentile), as measured by midtrimester transvaginal
ultrasonography, received either weekly intramuscular 17-α hydroxyprogesterone caproate
or placebo. The simple urn method of randomization, with stratification according to clinical
center, was used by the data coordinating center to create the computer-generated
randomization sequence.12 Women with a known last menstrual period were dated by their
ultrasonographic examination if a discrepancy existed of more than 7 days at less than 20
weeks of gestation and more than 14 days between 20 and 22 6/7 weeks of gestation. If the
last menstrual period was unknown, gestational age was established by the first
ultrasonographic examination using the standard method of ultrasonographic gestational age
determination at that institution. Full details of the study protocol have been previously
reported.12
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The present study is a secondary analysis of data from the Short Cervix and Nulliparity trial.
During the weekly study visits for the trial, participants were queried as to whether their
health care provider had recommended any of these forms of activity restriction: pelvic rest,
reduction of work activity, or reduction of nonwork activity. Those who did not answer
these questions were excluded from further analysis. “Pelvic rest” was defined as prohibition
of sexual activity. Those participants who had recommended reductions in work or nonwork
activity were further categorized according to whether the reduction in this activity was
partial (the recommendation allowed some work or nonwork activity to continue) or
complete (the recommendation was for all work and nonwork activity to cease). The
frequencies of different variations of activity restriction, and the median gestational age at
which they were recommended, were determined. Those women who had reductions in
either pelvic, work, or nonwork activity were classified as having had “any” activity
restriction.
Patient factors (both demographic and ultrasonographic) associated with any activity
restriction were estimated in univariable analysis. All ultrasonographic findings were
derived from the initial screening ultra-sonogram. We then explored the association between
activity restriction and preterm birth at less than 37 and less than 34 weeks of gestation. The
association was first estimated in univariable analysis and then in a multivariable logistic
regression. In addition to the activity restriction variable, other independent variables placed
in the multivariable regression were treatment group (ie, whether a patient received 17-a
hydroxyprogesterone caproate or placebo) and any patient factors that had been identified in
univariable analysis as being associated at P<.05 with having activity restriction
recommended. The interactions of activity restriction with 1) treatment group; 2) cervical
length; and 3) gestational age at screening also were assessed. In addition, the univariable
and multivariable analyses were repeated with “activity restriction” being defined only
according to whether women were recommended to forego work or nonwork activities (and
without regard to pelvic rest).
The Wilcoxon rank-sum test was used to compare continuous variables, the χ2 was used to
compare categorical variables, and the Breslow–Day test was used to test for interaction and
homogeneity of the odds ratio in stratified analyses. Multivariable analyses were performed
with multiple logistic regression with odds ratios (ORs) and 95% confidence intervals (CIs)
reported. All tests were two-tailed and P<.05 was used to define statistical significance. No
adjustments were made for multiple comparisons. All analyses were performed using SAS
9.2 (SAS Institute, Cary, NC) with Figure 1 constructed with the use of R (http://www.r-
project.org). The study was approved by the internal review boards at all participating
centers.
RESULTS
Of the 657 women who participated in the randomized trial, 646 (98%) responded to
questions regarding activity restriction. The frequencies of different forms of activity
restriction, and the median gestational ages at which they were first recommended, are
presented in Table 1. Nearly forty percent of women with a short cervix were prescribed
some form of activity restriction, most commonly in the midsecond to early third trimester,
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soon after the diagnosis of a short cervix was made. As illustrated by Figure 1, various
combinations of this restriction were used, although most commonly (171 of 252 [68%]), all
three types were combined.
Women who had any activity restriction recommended, compared with those who did not,
differed in many of their demographic characteristics and trans-vaginal ultrasonographic
findings (Table 2). Specifically, women who received recommendations for activity
restriction were older (P<.001), were more likely to have private insurance (P=.01), and
were less likely to be Hispanic white (P<.001). These women also had shorter cervical
lengths and were more likely to have cervical funneling or intra-amniotic debris, as assessed
by transvaginal ultrasonography.
Preterm birth at less than 37 weeks of gestation was significantly more common among
women placed on any activity restriction (37% compared with 17%, P<.001; OR 2.91, 95%
CI 2.0–4.21). No significant interactions between treatment with 17-α hydroxyprogesterone
caproate and activity restriction, cervical length less than 15 mm and activity restriction, or
gestational age at screening less than 20 weeks of gestation and activity restriction were
found and therefore these interactions were not assessed further (Breslow–Day for treatment
group: P=.67 at 37 weeks of gestation, P=.93 at 34 weeks of gestation; for cervical length:
P=.70 at 37 weeks of gestation, P=.82 at 34 weeks of gestation; for gestational age at
screening: P=.11 at 37 weeks of gestation, P=.40 at 34 weeks of gestation). After controlling
for treatment group and for the noted demographic and ultrasonographic differences among
those with and without activity restriction, preterm birth less at than 37 weeks of gestation
remained significantly more common among those placed on any activity restriction
(adjusted OR 2.37, 95% CI 1.60–3.53; Table 3). Similarly, preterm birth at less than 34
weeks of gestation was significantly more common among women placed on any activity
restriction (adjusted OR 2.28, 95% CI 1.36–3.80). Results were similar when only women
prescribed limitation of work and nonwork activities were included in the activity restriction
group (less than 37 weeks of gestation: adjusted OR 2.44, 95% CI 1.63–3.65; less than 34
weeks of gestation: adjusted OR 2.70, 95% CI 1.62–4.52).
DISCUSSION
This analysis reveals that some form of activity restriction was prescribed for more than one
in every three nulliparous women who were diagnosed with a short cervix. Activity
restriction, when it was recommended, was not narrowly confined to one aspect of a
woman’s life but was used such that it pervaded both work and home life. More than two
thirds of women who had activity restricted were recommended to refrain from work,
nonwork, and sexual activity. It is also of interest to note that activity restriction was not
always more likely to be prescribed to women with characteristics most associated with
preterm birth. For example, activity restriction was more common among women with
private insurance and less common among Hispanic white women than among non-Hispanic
white women. This finding suggests that variation in the use of activity restriction is
dependent not only on the perception of risk status, but on social factors as well.
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The use of such interventions would be understandable if they had been demonstrated to
reduce the frequency of preterm birth. However, there is no good evidence from randomized
trials that demonstrate that any of these forms of activity restriction are associated with
improved perinatal outcomes for women at increased risk of preterm birth.13 Fox et al14
specifically evaluated whether hospitalization was efficacious for women with a cervical
length 25 mm or less. In their retrospective analysis, admission to the hospital was not
associated with any decrease in the frequency of preterm delivery. Conversely, there was a
trend toward an earlier gestational age at delivery among those women hospitalized.
These results are similar to those of our study, in which women who were prescribed
activity restriction were significantly more likely to deliver preterm. This association
persisted even after controlling for potential confounding factors. It is possible that this
association is the result of unmeasured confounding. The most likely cause for unmeasured
confounding is that physicians prescribe bed rest to women whom they perceive to be at
greatest risk of preterm birth, and some of these factors were not accounted for in our
analysis. Yet we were able to prospectively collect and control for many factors, including
demographic information, medical history, and ultrasonographic findings that are known to
be associated with preterm birth. These are the same factors that would have been known to
physicians and would have been responsible for confounding. Conversely, even if there are
other unknown factors that predispose women to preterm birth, these would be unknown to
physicians as well and could not be responsible for confounding the observed association.
It is not biologically implausible that activity restriction could result in an increased risk of
preterm birth. Activity restriction has been associated with increased stress and anxiety, both
of which have been associated with an increased risk for adverse pregnancy outcomes,
including preterm and low-birth-weight deliveries, in multiple observational studies.15–17
Emotional ramifications are not the only consequence of activity restriction, which also has
been associated with an increased chance of venous thromboembolism, bone loss,
deconditioning, and financial difficulties.6,7 Even if there were to be no greater chance of
preterm birth with activity restriction, such potential complications underscore that this
intervention should be shown to be of benefit before it is used routinely for preterm birth
prophylaxis.
This study was performed among nulliparous women with a cervix less than 30 mm.
Accordingly, the results cannot be generalized to women who are at higher risk of preterm
delivery for other reasons. Also, compliance with activity restriction was not monitored, and
we cannot know whether the fidelity with which women followed their physicians’
recommendations was associated with the ultimate outcome.
Our data are relevant for the present debate regarding whether transvaginal ultrasonographic
cervical length screening during the second trimester should be routinely incorporated into
obstetric care. Support for such an approach comes from two cost-effectiveness analyses,
which suggested that a universal screening strategy would improve health outcomes and be
cost-saving.18,19 However, neither analysis incorporated the potential for unexpected
consequences from a screening program, including the frequent use of activity restriction for
women found to have a short cervical length. Use of such restriction will diminish both the
Grobman et al. Page 5






















financial advantages and health effectiveness of screening, even if the increased risk of
preterm birth associated with activity restriction is disregarded. This analysis suggests that,
if a cervical length screening program is to be adopted, and the putative health and economic
benefits of such a program are to be realized, clear guidelines regarding appropriate
responses to a positive finding should be adopted as well. In addition, the analysis
emphasizes the importance of conducting an adequately powered randomized trial for
women at increased risk of preterm birth such that level I evidence for the effects of activity
restriction can be obtained.
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Combinations of activity restriction among women with a cervical length less than 30 mm.
The numbers show the number of women who experienced each type or combination of
restrictions.
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Table 1
Frequency of and Gestational Age at Initiation of Different Types of Activity Restriction Among Nulliparous
Women With a Cervical Length Less Than 30 mm (N5646)
Type of Restriction Frequency Estimated Gestational Age (wk)
Pelvic rest 217 (33.6) 23.9 (22.7, 27.7)
Work restriction 196 (30.3) 24.1 (22.8, 28.7)
  Partial 52 (8.0) 24.8 (22.9, 29.8)
  Complete 144 (22.3) 25.0 (23.0, 29.6)
Nonwork restriction 212 (32.8) 23.9 (22.9, 28.2)
  Partial 89 (13.8) 24.4 (23.1, 28.7)
  Complete 123 (19.0) 24.7 (22.9, 29.6)
Work or nonwork restriction 221 (34.2) 23.9 (22.9, 28.6)
Work or nonwork restriction or pelvic rest 252 (39.0) 23.9 (22.6, 27.9)
Data are n (%) or median (25th, 75th percentile).
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Table 2
Association Between Demographic and Ultrasonographic Factors and Activity Restriction Among Nulliparous







  Active 131 (52.0) 190 (48.2)
  Placebo 121 (48.0) 204 (51.8)
Maternal age (y) 21.0 (20.0, 25.5) 20.0 (19.0, 23.0) >.001
Race or ethnicity .009
  Non-Hispanic white 63 (25.0) 86 (21.8)
  Hispanic white 9 (3.6) 46 (11.7)
  Black 140 (55.6) 197 (50.0)
  Asian 3 (1.2) 4 (1.0)
  Other 37 (14.7) 61 (15.5)
Insurance .03
  Private 66 (26.2) 70 (17.8)
  Government 172 (68.3) 292 (74.1)
  Self-pay 14 (5.6) 32 (8.1)
Estimated gestational age at cervical length measurement (wk) 20.3 (19.4, 21.1) 19.7 (18.7, 20.9) <.001
Cervical length (mm) 23.7 (19.0, 26.5) 26.5 (24.0, 28.3) <.001
Cervical funneling 74 (29.4) 77 (19.5) .004
  If funneling, length of funnel (mm) 14.8 (10.7, 19.4) 13.0 (7.4, 19.2) .07
Intra-amniotic debris 41 (16.3) 35 (8.9) .005
Data are n (%) or median (25th, 75th percentile) unless otherwise specified.
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Table 3
Adjusted Odds Ratios and 95% Confidence Intervals for the Association Between Patient Factors and Preterm
Birth at Less Than 37 Weeks of Gestation
Factor Odds Ratio 95% Confidence Interval P
Treatment group 0.99 0.68–1.46 .96
Maternal age (y)* 1.01 0.96–1.05 .76
Black race 1.07 0.72–1.58 .73
Public insurance 1.60 0.92–2.77 .10
Estimated gestational age at cervical length measurement (wk)* 1.02 0.89–1.16 .78
Cervical length (mm)* 0.93 0.90–0.97 <.001
Cervical funneling 1.20 0.72–2.00 .50
Intra-amniotic debris 0.96 0.53–1.73 .89
Any activity restriction 2.37 1.60–3.53 <.001
*
Odds ratio per 1 unit change.
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